换一批
换一批
作者：
Wei-Yu,Lin [1]
;
Sarah E,Fordham [1]
;
Eric,Hungate [2]
;
Nicola J,Sunter [1]
;
Claire,Elstob [1]
;
Yaobo,Xu [1]
;
Catherine,Park [1]
;
Anne,Quante [3]
;
Konstantin,Strauch [4]
;
Christian,Gieger [3]
;
Andrew,Skol [4]
;
Thahira,Rahman [4]
;
Lara,Sucheston-Campbell [2]
;
Junke,Wang [1]
;
Theresa,Hahn [5]
;
Alyssa I,Clay-Gilmour [5]
;
Gail L,Jones [6]
;
Helen J,Marr [7]
;
Graham H,Jackson [8]
;
Tobias,Menne [8]
;
Mathew,Collin [8]
;
Adam,Ivey [8]
;
Robert K,Hills [8]
;
Alan K,Burnett [9]
;
Nigel H,Russell [10]
;
Jude,Fitzgibbon [11]
;
Richard A,Larson [12]
;
Michelle M,Le Beau [13]
;
Wendy,Stock [2]
;
Olaf,Heidenreich [2]
;
Abrar,Alharbi [2]
;
David J,Allsup [1]
;
Richard S,Houlston [1]
;
Jean,Norden [14]
;
Anne M,Dickinson [15]
;
Elisabeth,Douglas [16]
;
Clare,Lendrem [16]
;
Ann K,Daly [16]
;
Louise,Palm [16]
;
Kim,Piechocki [16]
;
Sally,Jeffries [17]
;
Martin,Bornhäuser [17]
;
Christoph,Röllig [17]
;
Heidi,Altmann [18]
;
Leo,Ruhnke [19]
;
Desiree,Kunadt [20]
;
Lisa,Wagenführ [20]
;
Heather J,Cordell [20]
;
Rebecca,Darlay [20]
;
Mette K,Andersen [20]
;
Maria C,Fontana [20]
;
Giovanni,Martinelli [21]
;
Giovanni,Marconi [21]
;
Miguel A,Sanz [22]
;
José,Cervera [23]
;
Inés,Gómez-Seguí [24]
;
Thomas,Cluzeau [24]
;
Chimène,Moreilhon [24]
;
Sophie,Raynaud [25]
;
Heinz,Sill [26]
;
Maria Teresa,Voso [25]
;
Francesco,Lo-Coco [26]
;
Hervé,Dombret [25]
;
Meyling,Cheok [26]
;
Claude,Preudhomme [27]
;
Rosemary E,Gale [27]
;
David,Linch [27]
;
Julia,Gaal-Wesinger [28]
;
Andras,Masszi [29]
;
Daniel,Nowak [29]
;
Wolf-Karsten,Hofmann [30]
;
Amanda,Gilkes [31]
;
Kimmo,Porkka [31]
;
Jelena D,Milosevic Feenstra [32]
;
Robert,Kralovics [32]
;
David,Grimwade [33]
;
Manja,Meggendorfer [34]
;
Torsten,Haferlach [35]
;
Szilvia,Krizsán [35]
;
Csaba,Bödör [36]
;
Friedrich,Stölzel [37]
;
Kenan,Onel [38]
;
James M,Allan [38]
作者单位：
Translational and Clinical Research Institute, Newcastle University Centre for Cancer, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
[1]
Section of Pediatric Hematology and Oncology, University of Chicago, Chicago, IL, USA.
[2]
Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.
[3]
Ludwig-Maximilians-Universität München, Chair of Genetic Epidemiology, IBE, Faculty of Medicine, Munich, Germany.
[4]
College of Pharmacy, The Ohio State University, Columbus, OH, USA.
[5]
Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA.
[6]
Arnold School of Public Health, Department of Epidemiology & Biostatistics, University of South Carolina, Greenville, USA.
[7]
Department of Haematology, Freeman Hospital, Newcastle upon Tyne Hospitals National Health Service Foundation Trust, Newcastle upon Tyne, UK.
[8]
Department of Medical and Molecular Genetics, King's College Medical School, London, UK.
[9]
Nuffield Department of Population Health, University of Oxford, Oxford, UK.
[10]
Paul O'Gorman Leukaemia Research Centre, University of Glasgow, Glasgow, UK.
[11]
Department of Haematology, Nottingham University Hospitals NHS Trust, Nottingham, UK.
[12]
Barts Cancer Institute, Queen Mary University of London, London, UK.
[13]
Centre for Atherothrombosis and Metabolic Disease, Hull York Medical School, Hull, UK.
[14]
Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
[15]
Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
[16]
West Midlands Regional Genetics Laboratory, Birmingham Women's Hospital, Birmingham, UK.
[17]
Department of Haematological Medicine, The Rayne Institute, King's College London, London, UK.
[18]
National Center for Tumor Diseases NCT, Partner site Dresden, Dresden, Germany.
[19]
Medizinische Klinik und Poliklinik I, University Hospital Carl Gustav Carus Dresden, Technical University of Dresden, Dresden, Germany.
[20]
Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.
[21]
Department of Clinical Genetics, University Hospital Rigshospitalet, Copenhagen, Denmark.
[22]
Institute of Hematology "L. and A. Seràgnoli", University of Bologna, Bologna, Italy.
[23]
IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy.
[24]
Hematology Service, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
[25]
CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.
[26]
Hematology department, Cote d'Azur University, CHU of Nice, Nice, France.
[27]
Division of Hematology, Medical University of Graz, Graz, Austria.
[28]
Università di Roma Tor Vergata, Dipartimento di Biomedicina e Prevenzione, Rome, Italy.
[29]
Hôpital Saint-Louis, Institut Universitaire d'Hématologie, Université Paris Diderot, Paris, France.
[30]
Univ. Lille, Inserm, CHU Lille, UMR-S 1172 - JPArc - Centre de Recherche Jean-Pierre AUBERT Neurosciences et Cancer, F-59000, Lille, France.
[31]
Department of Haematology, University College London Cancer Institute, London, UK.
[32]
1st Department of Internal Medicine, Semmewleis University, Budapest, Hungary.
[33]
3rd Department of Internal Medicine, Semmewleis University, Budapest, Hungary.
[34]
Department of Hematology and Oncology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
[35]
Department of Haematology, University of Cardiff, Cardiff, UK.
[36]
Helsinki University Hospital Comprehensive Cancer Center, Hematology Research Unit Helsinki, University of Helsinki, Helsinki, Finland.
[37]
Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.
[38]
MLL Munich Leukemia Laboratory, Munich, Germany.
[39]
HCEMM-SE Molecular Oncohematology Research Group, 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
[40]
Medizinische Klinik und Poliklinik I, University Hospital Carl Gustav Carus Dresden, Technical University of Dresden, Dresden, Germany. friedrich.stoelzel@uniklinikum-dresden.de.
[41]
Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA. kenan.onel@mssm.edu.
[42]
Translational and Clinical Research Institute, Newcastle University Centre for Cancer, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK. james.allan@newcastle.ac.uk.
[43]
主题词
醛还原酶(Aldehyde Reductase);病例对照研究(Case-Control Studies);疾病遗传易感性(Genetic Predisposition to Disease);全基因组关联研究(Genome-Wide Association Study);基因型(Genotype);HLA抗原(HLA Antigens);人类(Humans);白血病, 髓样, 急性(Leukemia, Myeloid, Acute);中年人(Middle Aged);多态性, 单核苷酸(Polymorphism, Single Nucleotide);结果可重复性(Reproducibility of Results)
DOI
10.1038/s41467-021-26551-x
PMID
34716350
发布时间
2024-02-10
- 浏览2
Nature communications
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
